moxalactam has been researched along with Pyrexia in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (82.35) | 18.7374 |
1990's | 3 (17.65) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbruzzese, JL; Laskin, OL; Lipsky, JJ; McGaughey, MD; Rocco, LE; Skubitz, KM | 1 |
Alanis, A; Rehm, S; Weinstein, AJ | 1 |
Bodey, GP; Bolivar, R; Elting, L; Fainstein, V; Keating, MJ; McCredie, KB | 1 |
Barnes, RC; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ; Young, LS | 1 |
Britten, J; Caplan, E; deJongh, CA; Finley, RS; Fortner, CL; Newman, KA; Schimpff, SC; Wade, JC; Wiernik, PH | 1 |
Boas, J; Bruun, BG; Dombernowsky, P; Frimodt-Møller, N; Hansen, HH; Hansen, OP; Holländer, NH; Oturai, PS | 1 |
Ikoma, K; Ishihara, Y; Kanno, T; Kumamoto, M; Morishita, H; Mukobayashi, C; Nakae, Y; Nakazawa, K; Shimizu, T; Taniguchi, Y; Tuchihashi, S | 1 |
Fukuoka, M; Kusunoki, Y; Masuda, N; Matsui, K; Takada, M | 1 |
Boughton, BJ; Brown, RM; Harris, RI; Perry, DJ; Rhodes, EG; Welch, RS | 1 |
Evans, M; Playforth, MJ; Pollock, AV; Sauven, P; Smith, GM | 1 |
Bruckner, DA; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ | 1 |
Elliott, CR; Pater, JL | 1 |
Daly, PA; Fenelon, LE; McCann, SR; O'Brien, AJ; O'Dwyer, R | 1 |
Bow, EJ; Louie, TJ | 1 |
Carlisle, P; D'Olimpio, JT; McKitrick, JC; Miller, M; Sheridan, CA; Wiernik, PH; Wollner, DI | 1 |
De Jongh, CA; Drusano, GL; Finley, RS; Joshi, JH; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Tenney, JH; Thompson, BW | 1 |
Ernst, P; Friis, H; Hansen, HH; Hansen, SW; Vejlsgaard, R | 1 |
14 trial(s) available for moxalactam and Pyrexia
Article | Year |
---|---|
Prospective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infections.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Clinical Trials as Topic; Double-Blind Method; Female; Fever; Humans; Male; Middle Aged; Moxalactam; Prospective Studies; Random Allocation; Streptococcal Infections; Tobramycin; Urinary Tract Infections | 1983 |
Comparative efficacy and toxicity of moxalactam and the combination of nafcillin and tobramycin in febrile granulocytopenic patients.
Topics: Agranulocytosis; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Infections; Male; Moxalactam; Nafcillin; Prospective Studies; Random Allocation; Tobramycin | 1983 |
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients.
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fever; Hearing Loss; Humans; Kanamycin; Kidney; Kinetics; Moxalactam; Neoplasms; Piperacillin; Ticarcillin | 1982 |
Ceftriaxone versus latamoxef in febrile neutropenic patients: empirical monotherapy in patients with solid tumours.
Topics: Adult; Aged; Antineoplastic Agents; Bacteremia; Bacterial Infections; Ceftriaxone; Female; Fever; Humans; Male; Middle Aged; Moxalactam; Neutropenia; Prospective Studies; Respiratory Tract Infections; Urinary Tract Infections | 1993 |
A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer.
Topics: Adult; Aged; Bacterial Infections; Chi-Square Distribution; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Logistic Models; Lung Neoplasms; Male; Middle Aged; Moxalactam; Multivariate Analysis; Neutropenia; Random Allocation; Tobramycin; Treatment Outcome | 1991 |
Empirical treatment of febrile, neutropenic patients with tobramycin and latamoxef.
Topics: Agranulocytosis; Bacterial Infections; Drug Therapy, Combination; Fever; Humans; Immune Tolerance; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Moxalactam; Neutropenia; Prothrombin Time; Random Allocation; Tobramycin | 1987 |
Single-dose antibiotic prophylaxis of abdominal surgical wound infection: a trial of preoperative latamoxef against peroperative tetracycline lavage.
Topics: Abdominal Muscles; Adolescent; Adult; Aged; Clinical Trials as Topic; Enterobacteriaceae; Female; Fever; Humans; Intraoperative Care; Male; Middle Aged; Moxalactam; Premedication; Random Allocation; Staphylococcus; Streptococcus; Surgical Wound Infection; Tetracycline; Therapeutic Irrigation | 1986 |
Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Bacterial Infections; Cefoperazone; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation; Thienamycins | 1988 |
The effect of different measures of outcome on the results of studies of empiric antibiotic therapy in febrile neutropenic patients.
Topics: Acute Disease; Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Clinical Trials as Topic; Cloxacillin; Drug Therapy, Combination; Fever; Humans; Infection Control; Leukemia; Lymphoma; Moxalactam; Multicenter Studies as Topic; Neoplasms; Neutropenia; Prognosis; Random Allocation; Tobramycin | 1988 |
A comparative study of latamoxef disodium and gentamicin versus piperacillin and gentamicin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Middle Aged; Moxalactam; Piperacillin; Prospective Studies; Random Allocation | 1988 |
Changes in endogenous microflora among febrile granulocytopenic patients receiving empiric antibiotic therapy: implications for fungal superinfection.
Topics: Agranulocytosis; Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fungi; Gram-Negative Bacteria; Humans; Moxalactam; Mycoses; Ticarcillin; Tobramycin | 1987 |
A comparative trial of moxalactam plus ticarcillin and clavulanic acid or piperacillin as empiric antibiotic therapy for febrile cancer patients.
Topics: Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Moxalactam; Neoplasms; Penicillins; Piperacillin; Ticarcillin | 1987 |
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Blood Bactericidal Activity; Blood Coagulation Disorders; Clinical Trials as Topic; Drug Hypersensitivity; Drug Synergism; Drug Therapy, Combination; Fever; Hearing Disorders; Humans; Infections; Kanamycin; Kidney Diseases; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation | 1986 |
Latamoxef versus carbenicillin plus gentamicin or carbenicillin plus mecillinam in leukopenic, febrile patients with solid tumors.
Topics: Adult; Aged; Antineoplastic Agents; Carbenicillin; Cisplatin; Clinical Trials as Topic; Female; Fever; Gentamicins; Humans; Leukopenia; Male; Middle Aged; Moxalactam; Prospective Studies | 1986 |
3 other study(ies) available for moxalactam and Pyrexia
Article | Year |
---|---|
Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Escherichia coli Infections; Female; Fever; Humans; Klebsiella Infections; Leukemia; Lung Neoplasms; Lymphoma; Male; Middle Aged; Moxalactam; Neutropenia; Pseudomonas Infections; Sarcoma; Ticarcillin; Tobramycin | 1984 |
Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacteria, Anaerobic; Bacterial Infections; Child; Drug Evaluation; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Fever; Gram-Positive Bacteria; Humans; Infusions, Parenteral; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Piperacillin; Pseudomonas Infections; Random Allocation; Staphylococcal Infections | 1984 |
Subclinical syphilitic hepatitis, which was markedly worsened by a Jarisch-Herxheimer reaction.
Topics: Anti-Bacterial Agents; Drug Eruptions; Female; Fever; Hepatitis; Humans; Middle Aged; Moxalactam; Syphilis | 1999 |